 Sanofi NASDAQ: SNY announced a fresh acquisition on Monday morning. The sprawling pharmaceutical company said it has agreed to purchase biotech Principia Biopharma NASDAQ: PRNB for 100 per share in an all-cash transaction. Principia specializes in the development of drugs to treat autoimmune disorders, a very active product category in the pharmaceutical industry just now. 